Regions Financial Corp’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $258K | Buy |
1,192
+4
| +0.3% | +$765 | ﹤0.01% | 782 |
|
|
2026
Q1 | $218K | Sell |
1,188
-49
| -4% | -$9.03K | ﹤0.01% | 815 |
|
|
2025
Q4 | $218K | Buy |
+1,237
| New | +$202K | ﹤0.01% | 797 |
|
|
2025
Q1 | – | Sell |
-1,354
| Closed | -$207K | – | 819 |
|
|
2024
Q4 | $207K | Sell |
1,354
-340
| -20% | -$57.3K | ﹤0.01% | 788 |
|
|
2024
Q3 | $328K | Sell |
1,694
-1
| -0.1% | -$209 | ﹤0.01% | 683 |
|
|
2024
Q2 | $393K | Sell |
1,695
-643
| -28% | -$140K | ﹤0.01% | 622 |
|
|
2024
Q1 | $504K | Buy |
2,338
+465
| +25% | +$109K | ﹤0.01% | 597 |
|
|
2023
Q4 | $485K | Sell |
1,873
-66
| -3% | -$16.2K | ﹤0.01% | 595 |
|
|
2023
Q3 | $498K | Sell |
1,939
-249
| -11% | -$66.6K | ﹤0.01% | 564 |
|
|
2023
Q2 | $623K | Sell |
2,188
-55
| -2% | -$16.4K | 0.01% | 551 |
|
|
2023
Q1 | $623K | Buy |
2,243
+219
| +11% | +$60.6K | 0.01% | 556 |
|
|
2022
Q4 | $561K | Sell |
2,024
-24
| -1% | -$6.78K | 0.01% | 577 |
|
|
2022
Q3 | $546K | Sell |
2,048
-90
| -4% | -$19.1K | 0.01% | 560 |
|
|
2022
Q2 | $436K | Sell |
2,138
-5,781
| -73% | -$1.18M | ﹤0.01% | 616 |
|
|
2022
Q1 | $1.67M | Sell |
7,919
-455
| -5% | -$98.9K | 0.01% | 415 |
|
|
2021
Q4 | $2.01M | Buy |
8,374
+4,246
| +103% | +$1.09M | 0.02% | 384 |
|
|
2021
Q3 | $1.17M | Sell |
4,128
-1,063
| -20% | -$348K | 0.01% | 453 |
|
|
2021
Q2 | $1.8M | Sell |
5,191
-10,228
| -66% | -$3.1M | 0.02% | 394 |
|
|
2021
Q1 | $4.31M | Sell |
15,419
-25,367
| -62% | -$6.84M | 0.04% | 235 |
|
|
2020
Q4 | $9.99M | Sell |
40,786
-2,931
| -7% | -$756K | 0.1% | 149 |
|
|
2020
Q3 | $12.4M | Buy |
43,717
+2,073
| +5% | +$578K | 0.14% | 135 |
|
|
2020
Q2 | $11.1M | Buy |
41,644
+11,988
| +40% | +$3.6M | 0.13% | 134 |
|
|
2020
Q1 | $9.38M | Buy |
29,656
+27,890
| +1,579% | +$8.46M | 0.12% | 141 |
|
|
2019
Q4 | $524K | Sell |
1,766
-60
| -3% | -$16.6K | 0.01% | 524 |
|
|
2019
Q3 | $425K | Sell |
1,826
-518
| -22% | -$121K | ﹤0.01% | 559 |
|
|
2019
Q2 | $548K | Sell |
2,344
-302
| -11% | -$69.7K | 0.01% | 510 |
|
|
2019
Q1 | $625K | Sell |
2,646
-163
| -6% | -$51.3K | 0.01% | 498 |
|
|
2018
Q4 | $845K | Sell |
2,809
-66
| -2% | -$21.1K | 0.01% | 422 |
|
|
2018
Q3 | $1.01M | Sell |
2,875
-27
| -0.9% | -$9.3K | 0.01% | 427 |
|
|
2018
Q2 | $843K | Sell |
2,902
-72
| -2% | -$20.2K | 0.01% | 455 |
|
|
2018
Q1 | $815K | Sell |
2,974
-327
| -10% | -$102K | 0.01% | 455 |
|
|
2017
Q4 | $1.05M | Buy |
3,301
+90
| +3% | +$28.9K | 0.01% | 416 |
|
|
2017
Q3 | $1.01M | Sell |
3,211
-1,840
| -36% | -$545K | 0.01% | 424 |
|
|
2017
Q2 | $1.37M | Buy |
5,051
+76
| +2% | +$20.1K | 0.02% | 374 |
|
|
2017
Q1 | $1.36M | Sell |
4,975
-130
| -3% | -$36.8K | 0.02% | 408 |
|
|
2016
Q4 | $1.45M | Buy |
5,105
+33
| +0.7% | +$9.78K | 0.02% | 397 |
|
|
2016
Q3 | $1.59M | Buy |
5,072
+135
| +3% | +$40K | 0.02% | 355 |
|
|
2016
Q2 | $1.19M | Sell |
4,937
-392
| -7% | -$103K | 0.02% | 450 |
|
|
2016
Q1 | $1.39M | Sell |
5,329
-672
| -11% | -$178K | 0.02% | 417 |
|
|
2015
Q4 | $1.84M | Sell |
6,001
-808
| -12% | -$232K | 0.02% | 337 |
|
|
2015
Q3 | $1.99M | Sell |
6,809
-2,066
| -23% | -$682K | 0.03% | 310 |
|
|
2015
Q2 | $3.58M | Buy |
8,875
+530
| +6% | +$213K | 0.05% | 210 |
|
|
2015
Q1 | $3.52M | Buy |
8,345
+105
| +1% | +$41.4K | 0.05% | 215 |
|
|
2014
Q4 | $2.8M | Sell |
8,240
-25,964
| -76% | -$8.4M | 0.04% | 242 |
|
|
2014
Q3 | $11.3M | Sell |
34,204
-1,039
| -3% | -$343K | 0.14% | 142 |
|
|
2014
Q2 | $11.1M | Buy |
35,243
+1,013
| +3% | +$305K | 0.14% | 143 |
|
|
2014
Q1 | $10.5M | Sell |
34,230
-2,165
| -6% | -$687K | 0.13% | 141 |
|
|
2013
Q4 | $10.2M | Sell |
36,395
-6,325
| -15% | -$1.64M | 0.13% | 137 |
|
|
2013
Q3 | $10.3M | Sell |
42,720
-3,333
| -7% | -$746K | 0.14% | 132 |
|
|
2013
Q2 | $9.91M | Buy |
+46,053
| New | +$9.84M | 0.14% | 130 |
|
Other funds holding BIIB
Regions Financial Corp's BIIB Position: Q2 2026 in Review
Regions Financial Corp increased its Biogen (BIIB) stake by 0.34% in Q2 2026, buying an estimated $765 and bringing the position to 1,192 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #782.
Regions Financial Corp first reported a position in BIIB in Q2 2013 and has held it in 50 quarters since. The position peaked at $12.4M in Q3 2020. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Regions Financial Corp held 1,192 shares of Biogen worth $258K as of Q2 2026.
- Regions Financial Corp bought 4 Biogen shares in Q2 2026, an estimated $765.
- Biogen made up ﹤0.01% of Regions Financial Corp's portfolio in Q2 2026, its #782 holding.
- Regions Financial Corp first reported a position in Biogen in Q2 2013 and has held it in 50 quarters since.
- Regions Financial Corp's Biogen position peaked at $12.4M in Q3 2020.
- 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.